Our Statement on COVID-19


The Spatial Biology Company™


Akoya Launches Two New, Fully Optimized PD-1/PD-L1 Panels for Immuno-Oncology Biomarker Analysis of Melanoma and Lung Cancer


Akoya expands solutions for translational immuno-oncology analysis, with two new Opal™ MOTiF-based kits for deep tissue profiling of the tumor microenviroment with clinically-relevant biomarkers, including PD-1 and PD-L1, in Melanoma and Lung Cancer samples. These automation-ready staining kits include six ready-to-use primary antibodies, staining and assay reagents for analysis on the Vectra® Polaris™.  The new kits were presented at the 2019 Society for Immunotherapy of Cancer (SITC) annual meeting at the Akoya workshop and multiple poster presentations. Click here to read the full announcement. An overview of the new panels was presented in a live webinar. Click here to view the recording.

Feature Image


  • Fully customizable panels for simultaneous analysis of up to 50 biomarkers
  • Sophisticated software suite for spatial characterization of tissue microenvironment
  • Walk-away automation through seamless integration with existing microscopes
Feature Image


  • Enhanced understanding of the underlying mechanisms leading to disease
  • Unparalleled quantitative multiplex analysis with precise autofluorescence removal
  • One platform harmonizing Opal reagents, multispectral digital pathology & scalable image analysis